Stocktoria
LifeMD, Inc. LFMD
Nasdaq · stock · Services-Offices & Clinics of Doctors of Medicine · website · IPO 2001-07-11
LifeMD, Inc. financials (annual)
Bars are annual figures from 2016 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $194.1M | $154.8M | $152.5M | $119.0M | $92.9M | $37.3M | $12.5M | $8.3M | $5.0M | $5.2M |
| Gross profit | $166.3M | $133.4M | $133.6M | $100.4M | $74.9M | $28.4M | $9.9M | $6.3M | $2.7M | $3.3M |
| Operating income | -$7.7M | -$20.4M | -$14.5M | -$43.4M | -$54.3M | -$57.8M | -$2.9M | -$2.1M | -$1.2M | -$1.2M |
| Interest expense | $1.4M | $2.2M | $2.6M | $1.3M | $3.0M | $1.7M | $761,150 | $354,388 | $100,523 | $48,611 |
| Income tax | $45,721 | $598,000 | $428,000 | $360,700 | $7,700 | $122,500 | -$122,500 | -$124,700 | — | — |
| Net income | $14.4M | -$21.4M | -$20.6M | -$45.5M | -$60.9M | -$58.6M | -$3.1M | -$1.2M | -$1.2M | -$1.1M |
| EPS (diluted) | $0.25 | $-0.60 | — | — | — | — | — | — | $-0.03 | $-0.03 |
| Operating cash flow | $8.3M | $17.5M | $8.8M | -$22.9M | -$33.1M | -$12.1M | $251,408 | -$905,519 | -$817,216 | -$407,914 |
| Free cash flow | $6.4M | $16.0M | $8.6M | -$23.3M | -$33.3M | — | — | — | — | — |
| Cash & equivalents | — | $35.0M | $33.1M | $4.0M | $41.3M | $9.2M | $1.1M | $180,093 | $141,379 | $182,561 |
| Inventory | $2.8M | $2.8M | $2.8M | $3.7M | $1.6M | $1.3M | $950,059 | $1.0M | $681,258 | $160,270 |
| Total assets | $70.4M | $76.1M | $58.5M | $25.7M | $49.9M | $13.4M | $3.4M | $2.6M | $1.3M | $789,824 |
| Total liabilities | $47.3M | $83.7M | $52.9M | $33.0M | $24.1M | $14.2M | $4.6M | $1.8M | $640,971 | — |
| Shareholders' equity | $23.2M | -$9.1M | $4.2M | -$11.9M | $22.7M | -$4.5M | -$1.1M | $897,700 | $881,923 | -$361,725 |
Growth · year-over-year · Revenue CAGR 49.4%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +25.3% | +1.5% | +28.2% | +28.2% | +149.0% | +199.1% | +49.8% | +66.5% | -4.6% | +329.8% |
| Free cash flow growth | -60.1% | +86.3% | — | — | — | — | — | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.